An MIT Sloan alum argues an MBA remains a viable route into healthcare leadership, explaining how the degree complements life-sciences training and opens roles in consulting, strategy, and management for hospitals, biopharma and global health NGOs. The piece lays out program-selection criteria—reputation, healthcare focus, and entrepreneurial support—that guided the author’s choice of Sloan. The author describes using an MBA to pivot from biomedical research to operations and policy work, citing a year-long project rebuilding Pakistan’s tuberculosis supply chain as decisive. The account underscores how management training supplies frameworks for scaling health programs and negotiating public–private partnerships. For prospective students and university career offices, the reporting clarifies who benefits most from an MBA in healthcare: candidates seeking cross-sector leadership, operational roles, or entrepreneurial paths rather than bench research. Admissions teams should expect continued demand from life-sciences professionals looking to transition into management and systems roles.